Experimental SARS Treatment Can Also Fight MERS

An experimental compound that has been shown to effectively treat Severe Acute Respiratory Syndrome (SARS) may also work equally well in treating Middle East respiratory syndrome (MERS), a new study suggests. This same drug has even proven effective at treating a hepatitis virus in mice (MHV), causing researchers to suspect that it could be used to target a broad spectrum of coronaviruses, despite subtle differences in how they present themselves.